Latest market headlines for CIPLA on Terminal.
23-Oct-2026 09:03:33
• USFDA conducted a routine cGMP inspection at InvaGen Pharmaceuticals Inc.'s manufacturing facility in Hauppauge, Long Island, New York, USA • Inspection was…
03-Sept-2026 20:14:20
• Strategic partnership for exclusive licensing and supply of QL2107, a biosimilar to Keytruda® (pembrolizumab), for the United States. • Qilu responsible for…
03-Sept-2026 16:51:02
• Scheme of Amalgamation notices being sent to shareholders and creditors. • Representations, if any, can be made to the NCLT within 30 days of receipt of noti…
31-Aug-2026 15:55:50
CIPLA : EXPANDS ONCOLOGY PORTFOLIO WITH NEW LICENSING AGREEMENT
28-Aug-2026 21:11:36
• Cipla Limited provided an update on the USFDA inspection at its wholly owned subsidiary, InvaGen Pharmaceuticals Inc.'s, manufacturing facility in Central Is…
25-Aug-2026 16:12:55
• United States Food and Drug Administration (USFDA) conducted a follow-up inspection of the Company's manufacturing facility at Pithampur, India from August 1…
18-Jul-2026 09:33:06
• Inspection conducted by USFDA at InvaGen manufacturing facility in Central Islip, Long Island, NY, USA from July 13-17, 2026. • The inspection was a routine…
12-Jun-2026 19:06:13
CIPLA says Plan Now Is To Make More Globally-relevant Innovations | Aim Is To Notch 10% Of Total Revenue From Innovations In The Next 5 Years
12-Jun-2026 19:06:13
Plan Now Is To Make More Globally-relevant Innovations Aim Is To Notch 10% Of Total Revenue From Innovations In The Next 5 Years
12-Jun-2026 19:06:13
Close To Half Of The Manufacturing From Goa Is Supplied To The US New Units Established With The Aim To De-risk And Diversify The Manufacturing Process
12-Jun-2026 19:06:13
Cipla CEO Gupta Rules Out Promoter Stake Sale For Now
12-Jun-2026 19:06:11
• 🇺🇸 USFDA has classified the inspection at Cipla's Verna, Goa manufacturing facility as Voluntary Action Indicated (VAI) • 🏭 The inspection included a rout…